Pawlitzki, M., Campe, C., Rolfes, L., Heinze, H., Leypoldt, F., Wandinger, K., . . . Körtvélyessy, P. (2020). Transient MOG antibody seroconversion associated with immunomodulating therapy. Multiple Sclerosis and Related Disorders, 37, . https://doi.org/10.1016/j.msard.2019.101420
Chicago Style (17th ed.) CitationPawlitzki, Marc, et al. "Transient MOG Antibody Seroconversion Associated with Immunomodulating Therapy." Multiple Sclerosis and Related Disorders 37 (2020). https://doi.org/10.1016/j.msard.2019.101420.
MLA (9th ed.) CitationPawlitzki, Marc, et al. "Transient MOG Antibody Seroconversion Associated with Immunomodulating Therapy." Multiple Sclerosis and Related Disorders, vol. 37, 2020, https://doi.org/10.1016/j.msard.2019.101420.
Warning: These citations may not always be 100% accurate.